Co-Diagnostics (CODX) announced that it has filed a Certificate of Amendment to its Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio of 1-for-30 shares. The ...
Kerala faces a third year of high leptospirosis deaths. Learn about the spread, prevention, and urgent need for timely ...
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
TipRanks on MSN
2 new IPO stocks enter the fray; JP Morgan says 'buy'
In this past year, we’ve seen the IPO market stabilize after several years of large-scale uncertainties – think post-COVID ...
From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...
Through December 10, the world has seen 502,264 chikungunya cases worldwide, with 291,451 in the Americas region alone ...
For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...
IOC President Kirsty Coventry is ready to bring back the genetic tests that had been abandoned for over 30 years, and also ...
At the Special Meeting of Stockholders held on December 5, 2025, the Company’s stockholders approved a reverse stock split of ...
Asianet Newsable on MSN
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval
Shares of Co-Diagnostics Inc. (CODX) slumped 20% to an all-time low after the company announced a 1-for-30 reverse stock ...
The Global Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback